1. Berghmans T, Lievens Y, Aapro M et al. European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer. Lung Cancer 2020; 150: 221–239. doi:10.1016/j.lungcan.2020.08.017

2. Essential Requirements for Quality Cancer Care. European Cancer Organisation. (accessed December 2, 2020).

3. EU4Health 2021-2027 – A vision for a healthier European Union. European Commission. (accessed November 25, 2020).

4. Members of the Mission Board for Cancer, Barros PP, Beets-Tan R et al. Proposed Mission. Conquering cancer: Mission possible. Report of the Mission Board for Cancer. Brussels: European Commission; 2020.

5. Goldstraw P, Chansky K, Crowley J et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2016; 11: 39–51.doi: 10.1016/j.jtho.2015.09.009

6. EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) – Epidemiology Forecast to 2025. London: GlobalData; 2016.

7. Lung Ambition Alliance. (accessed December 28, 2020).

8. Early Lung Imaging Confederation (ELIC). International Association for the Study of Lung Cancer. http:// (accessed December 31, 2020).

9. Improved Quality Care. Lung Ambition Alliance. (accessed January 4, 2020).

10. TERAVOLT. Thoracic cancERs international coVid 19 cOLlaboraTion registry for thoracic cancers. (accessed January 4, 2020).

11. Conference - Europe’s Beating Cancer Plan: Let’s strive for more. European Commission. (accessed November 17, 2020).

12. Planchard D, Popat S, Kerr K et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29 Suppl 4:iv192–iv237. doi: 10.1093/ annonc/mdy275

13. Pennell NA, Arcila ME, Gandara DR et al. Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices. Am Soc Clin Oncol Educ Book 2019; 39: 531–542. doi: 10.1200/EDBK_237863

14. A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) (B-FAST). NCT03178552 (accessed January 4, 2020).

15. The Economist Intelligence Unit Healthcare. Breathing in a new era: a comparative analysis of lung cancer policies across Europe. London: The Economist Intelligence Unit; 2020.

16. Ismail RK, Schramel FMNH, van Dartel M et al. The Dutch Lung Cancer Audit: Nationwide quality of care evaluation of lung cancer patients. Lung Cancer 2020; 149: 68–77. doi: 10.1016/j.lungcan.2020.08.011